ACCUMULATED EVIDENCES on mast cell functions show their central role in allergic reactions and strong involvement in innate and acquired immunities (6, 16, 30, 42) . Mast cells degranulate and release various types of inflammatory mediators in response to antigen exposure and IgE aggregation. However, a different type of stimulation frequently alters the cell membrane permeability and initiates prostanoid production in mast cells (29) . In fact, nerve growth factor induces prostaglandin (PG) D 2 production in mast cells without causing degranulation (29, 33) . Since the final metabolite of PG known as 15-deoxy-delta 12,14-prostaglandin J 2 (15-deoxy-delta PGJ 2 ) is excreted daily in the urine, it has been suggested that this compound plays a role in homeostasis and diseases (18, 25, 41) . Recent studies have demonstrated that the J 2 series of PGs act as natural ligands for the peroxisome proliferator-activated receptor (PPAR) ␥ and modulate glucose uptake in the fat tissue and skeletal muscle via the activation of PPAR␥ (4, 12, 14, 25) .
PPARs are members of the nuclear hormone receptor superfamily of ligand-activated transcription factors that are related to retinoid, steroid, and thyroid hormone receptors (4, 11, 22, 39) . Three subtypes of PPAR (␣, ␤, and ␥) have been identified, and these receptors are thought to play an important role in metabolic diseases such as obesity, insulin resistance, and coronary artery disease (11) . Since PPARs appear to be closely involved in the regulation of dietary fat storage and catabolism, they have been established as an important target for the treatment of type II diabetes (11) . By activating a number of genes in tissues, PPAR␥ increases glucose and lipid uptake, promotes glucose oxidation, decreases a free fatty acid concentration, and restrains insulin resistance (4, 11, 12, 14, 22, 25, 39) . Thiazolidinediones (TZDs) were identified as PPAR␥ ligands, constituting a new class of antidiabetic drugs by acting as insulin sensitizers (11) . PPAR␥ agonists increase peripheral insulin sensitivity by inducing the transcription of genes relating to insulin-stimulated glucose uptake particularly in the fat tissue and skeletal muscle, leading to reduction in circulating levels of free fatty acids and promotion of adipocyte differentiation (4, 11, 22, 39) . Since PPAR␥ modulates insulin sensitivity of adipocytes and myocytes, synthetic PPAR␥ agonists have clinical relevance in the treatment of type II diabetes (4, 11, 22, 39) . TZD and insulin stimulate the expression of an adipocyte-specific gene (aP2) in adipocytes in a synergistic manner (1, 46) . The final metabolite of PGD 2 (15-deoxy-delta PGJ 2 ) is one of the major endogenous PPAR␥ agonists (18, 25) . As well as TZD, 15-deoxy-delta PGJ 2 is responsible for activating PPAR␥ and has been indicated to induce adipocyte differentiation (25, 36) . Mast cells are a major producer of PGD 2 that is easily synthesized from arachidonic acid following a change in the membrane permeability (21, 26, 35) . Therefore, we speculated that the final metabolite of the PG produced from mast cells might act as a ligand for PPAR␥ and play a certain role in adipogenesis.
The recent study has revealed the involvement of mast cells in obesity via the induction of angiogenesis in adipose tissues (28) ; however, the contribution of mast cells in adipogenesis remains uncertain. In this study, we investigated whether mast cells could modulate adipocyte differentiation and found that culture supernatants from activated mast cells induced differentiation of 3T3 L1 cells and primary preadipocytes into adipocytes. We further demonstrated that PG production by mast cells was promoted in the high-glucose conditions, and PG produced from mast cells could activate PPAR␥ resulting in adipocyte differentiation. Here we report the novel role of mast cells in adipogenesis.
MATERIALS AND METHODS
Research design. We found that the increase of mast cell numbers in fat tissue of obese mice with high-fat feeding was obvious; therefore, the involvement of mast cells in adipogenesis was speculated. Mast cells are one of the major producers of PGs, whose final metabolite 15-deoxy-delta PGJ 2 is the endogenous ligand of PPAR␥. Since much is known regarding that PPAR␥ activation modulates adipocyte differentiation, we investigated the role of mast cells in adipogenesis focusing on PGJ 2 (24, 40) . Hematopoietic PGD synthase (H-PGDS)-deficient mice (C57BL/6 background) were kindly provided from Dr. Yoshiaki Urade (Osaka Bioscience Institute, Osaka, Japan). In H-PGDS-deficient mice, productivity of PGDS only in hematopoietic cells is lost (10) . All experiments with animals were complied with the standards in the guidelines of the University Animal Care and Use Committee in Tokyo University of Agriculture and Technology.
Bone marrow-derived cultured mast cells (BMCMC) were generated by incubating bone marrow cells obtained from WBB6F1ϩ/ϩ mice or H-PGDS-deficient mice with recombinant mouse (rm) interleukin (IL)-3 (kindly provided by Kirin Brewery, Tokyo, Japan) as described (10, 37) . Cells were used for experiments after being cultured for 6 to 7 wk. Tissue-derived cultured mast cells were generated by incubating cells isolated from adipose tissue of C57BL/6 mice with rmIL-3 and recombinant rat stem cell factor (Bioclone, San Diego, CA) for 3 to 4 wk, according to the procedure regarding skin-derived mast cells (20) . Cultured mast cells (both BMCMC and tissue-derived mast cells) were positive for CD117 and Fc⑀ receptor I by flow cytometoric analysis and contained metachromatic granules in their cytosol by toluidine blue staining (data not shown). The phenotype represents connective tissue-type mast cells. 3T3 L1 cells were purchased from Japanese Collection of Research Bioresources (Osaka, Japan). Pioglitazone, a PPAR␥ agonist, was purchased from Takeda Chemical Industries (Osaka, Japan), and GW9662, a selective PPAR␥ antagonist, was from Cayman Chemical (Ann Arbor, MI). Unless otherwise indicated, all chemicals were purchased from SigmaAldrich (St. Louis, MO).
Reconstitution of mast cells. BMCMC were freshly isolated from WBB6F1ϩ/ϩ mice or from H-PGDS-deficient mice (indicated as H-PGDSϪ/Ϫ), and the cells (2 ϫ 10 7 BMCMC/mouse that were cultured with rmIL-3 for 5-6 wk) were injected intravenously into 4-to 5-wk-old male WBB6F1-W/W v mice. After 7-8 wk of transplantation, the packed cell was determined to elucidate the difference between bone marrow and BMCMC transplantation.
Assays for 15-deoxy-delta PGJ2 and other adipogenesis-relating factors. Concentrations of 15-deoxy-delta PGJ2 were measured by using an enzyme-linked immunosorbent assay (ELISA) kit (Assay Designs, Ann Arbor, MI) according to the instructions. Serum levels of tumor necrosis factor (TNF)-␣, resistin, leptin, and adiponectin were measured by using ELISA kits (R&D systems, Minneapolis, MN) according to each instruction.
High-fat feeding and pioglitazone treatment. Six-week-old mice were supplied with a high-fat diet (CRF-1 with 40% lard; Charles River Japan, Yokohama, Japan) ad libitum for 28 days. After the mice received high-fat feeding for 28 days, pioglitazone was mixed with the high-fat diet (0.02%, wt/wt) and orally administered to WBB6F 1-W/W v mice for the next 21 days. Subsequently, serum concentrations of triglyceride (TG) (Fuji Drychem Slides TG, Fujifilm Medical, Tokyo, Japan) and nonessential fatty acid (NEFA) (Wako NEFA C kit; Wako Chemicals, Richmond, VA) were determined before and after the treatment.
Reporter gene assay. PPAR responsive element (PPRE) reporter plasmids conjugated with the luciferase gene (PPRE along with a J-site cloned upstream of the TK promoter in the pGL3 luciferase expression vector, kindly provided from Dr. Bart Staels in Institute Pasteur, Lille, France) were transfected into NIH 3T3 fibroblasts using Lipofectamine 2000 Reagent (Invitrogen, Tokyo, Japan) according to the instruction. Transfected NIH 3T3 fibroblasts were cultured with the supernatants of BMCMC stimulated with 1 M A23187 for 24 h. We used 15-deoxy-delta PGJ 2 (Calbiochem, Meudon, France) as a positive control and culture medium containing 1 M A23187 supplemented with 10% fetal bovine serum as a negative control. To evaluate the transfection efficiency, the luciferase activity of the cells was analyzed by a luciferase assay using the ␤-galactosidase expression vector (pCMV␤). The luciferase activity in the supernatants of the cell lysates was measured with the Bright-Glo luciferase assay system (Promega, Madison, WI) as a substrate.
Induction of adipocyte differentiation. BMCMC (2.5 ϫ 10 7 cells/ ml) generated from WBB6F1ϩ/ϩ mice or H-PGDS-deficient mice were cultured for 72 h in the high-glucose condition (50 mM) and supernatants were collected. 3T3 L1 cells were maintained in StemXVivo adipogenic base media (R&D systems) and then incubated for 10 days with or without collected supernatants for the induction of adipocyte differentiation. For a positive control in each experiment, StemXVivo radiogenic supplement (R&D systems) was used to induce adipocyte differentiation. Dedifferentiated fat (DFAT) cells were obtained from white adipose tissue of C57BL/6 mice with the ceiling culture method (44) . Differentiation of DFAT cells was induced as described above. Adipocyte differentiation was evaluated by oil red O (ORO) staining.
Real-time polymerase chain reaction analysis. White adipose tissue was collected from WBB6F 1-W/W v mice fed with a high-fat diet for 4 wk. Isolation of tRNA, generation of cDNA, and a polymerase chain reaction (PCR) analysis for gene expression of TNF-␣, resistin, leptin, and adiponectin were performed with specific primers (purchased from Takara Bio, Tokyo, Japan) as described (38) .
Histological examinations for mast cells. Metabolic tissues (liver, spleen, subcutaneous fat tissue, skin, and skeletal muscle) were
sh /W sh mice and fixed with 4% paraformaldehyde. Mast cells were identified by toluidine blue staining (pH 4.0), and their numbers were counted under a microscope at a magnification of ϫ100 and were expressed as the total number of the cells in five fields.
RESULTS

Mast cells in adipose tissue and skeletal muscle.
In our histological observation of various tissues in mice, large numbers of mast cells were found in adipose tissue with toluidine blue staining. Mast cells were also found in intermusclar fibrotic and fat tissue but not in parenchyma of muscles. To obtain evidence on the possible relationship of mast cells in adipogenesis, we counted mast cell numbers in adipose tissue and skeletal muscle isolated from WBB6F 1 ϩ/ϩ, WBB6F 1 (Fig. 1, A and B) . We found quite a few mast cells in the liver of WBB6 F 1 ϩ/ϩ mice (data not shown). These observations allowed us to speculate that mast cells might play a certain role in the maintenance of adipose tissues.
Increase in numbers of mast cells in adipose tissue of obese mice. To examine whether mast cells were involved in the growth of fat tissues, WBB6F 1 ϩ/ϩ mice were fed a high-fat diet for 8 wk, and mast cell numbers in metabolic tissues were counted. In obese WBB6F 1 ϩ/ϩ mice, mast cell numbers in subcutaneous adipose tissues and skeletal muscles were increased (Fig. 1C) . Particularly, mast cells were found in intermusclar fat tissues (Fig. 1B) , suggesting the interaction between mast cells and adipocytes. Alterations in adipose tissue amount and morphology in mast cell-deficient mice were not obvious by analysis with computed tomography compared with that of wild-type mice (data not shown).
Capability of mast cells for adipocyte differentiation. To evaluate ability of mast cells in adipogenesis, adipocyte differentiation of 3T3 L1 cells was induced using supernatants of BMCMC that were cultured in the high-glucose (50 mM) condition for 72 h. When 3T3 L1 cells were incubated with adipogenic supplement for 10 days, ORO-positive cells were increased ( Fig. 2A) . ORO-positive cells were also increased when culture supernatants of BMCMC were supplied to 3T3 L1 cells. Since PPAR␥ plays the critical role in adipocyte differentiation, the effect of a selective PPAR␥ antagonist (GW9662) (27) on mast cell-mediated adipogenesis was evaluated. As shown in Fig. 2A , the efficacy of mast cells on induction of adipocyte differentiation was canceled by the addition of GW9662. Since mast cells are a major producer of PGs, and the final metabolite of PGs (15-deoxy-delta PGJ 2 ) is one of activators of PPAR␥, we examined the possible involvement of mast cell-derived PGs in adipogenesis by generating BMCMC from bone marrow cells of H-PGDS-deficient mice and collected supernatants of H-PGDS-deficient BMCMC cultured in the high-glucose condition. Supernatants collected from BMCMC of H-PGDS-deficient mice failed to induce adipocyte differentiation of 3T3 L1 cells (Fig. 2A) . We also confirmed the ability of mast cells to induce adipocyte differentiation using primary DFAT cells. Incubation of DFAT cells for 10 days in supernatants of BMCMC obtained according to the described procedure induced adipocyte differentiation. Compared with DFAT cells incubated with adipogenic supplement, lipid droplets in cells incubated in BMCMC supernatants were stained strongly with ORO (Fig. 2B) . Increased numbers of small lipid droplets were recognized in cells incubated in BMCMC supernatants (Fig. 2B) . However, no difference was identified in adipocyte morphology even when DFAT cells were incubated in BMCMC supernatant or in differentiation Fig. 1 . Identification of mast cells in metabolic tissues. A: in metabolic tissues (subcutaneous fat tissue and skeletal muscle), the number of toluidine blue-positive mast cells was counted under a microscope at a magnification of ϫ100 and was expressed as the total number in five fields. Data represents means Ϯ SE of 10 mice in each group. B: microscopic features of subcutaneous fat and skeletal muscles obtained from each mouse with toluidine blue staining. Mast cells are found in fat or fibrotic tissues of skin and skeletal muscles. C: identification of mast cells in metabolic tissues collected from obese mice. Subcutaneous fat tissue and skeletal muscle were obtained from each mouse fed with a high-fat diet and histologically identified by toluidine blue staining. Mast cell numbers were counted under a microscope at a magnification of ϫ100 and were expressed as the total number in five fields. Data represents means Ϯ SE of 10 mice in each group. *P Ͻ 0.05 when compared with mast cell numbers in mice fed with normal chow. medium with adipogenic factors. Supernatants of H-PGDSdeficient BMCMC failed to induce adipocyte differentiation (Fig. 2B) .
Presence of 15-deoxy-delta PGJ 2 in culture medium of mast cells. Next, we attempted to examine whether mast cells could produce 15-deoxy-delta PGJ 2 in the high-glucose conditions. To examine whether alteration in membrane permeability induces PG generation, BMCMC were stimulated with the calcium ionophore A23187 for 24 h. Significant levels of 15-deoxy-delta PGJ 2 were detected in supernatants (Fig. 3A) , suggesting that PGs synthesized by BMCMC might be converted into 15-deoxy-delta PGJ 2 in culture medium. Furthermore, when BMCMC derived from the control WBB6F 1 ϩ/ϩ mice were incubated with various concentrations of glucose for 72 h, 15-deoxy-delta PGJ 2 was detected in culture supernatants in a dose-dependent manner (Fig. 3B) . However, 15-deoxydelta PGJ 2 concentrations in supernatants of H-PGDS-deficient BMCMC in the high-glucose conditions were under the detection limit (data not shown). Moreover, we examined roles of tissue-derived mast cells in adipogenesis. Subcutaneous fat tissue-derived cultured mast cells were generated and cultured in the high-glucose conditions. As well as BMCMC indicated in Fig. 4B, 15 -deoxy-delta PGJ 2 production from subcutaneous fat tissue-derived cultured mast cells was upregulated accompanied by increased glucose concentrations in culture media (Fig. 3C) . After 72 h of culture in the high-glucose conditions, neither degranulation nor cell death of mast cells was noticed by cytospin preparations (morphological observation) and a 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide (MTT) assay (data not shown). To test whether a high concentration of glucose induces degranulation of mast cells in vivo, the mesentery was recovered after intrperitoneal injection of glucose (1.5 mg/g of body wt) and stained with acidified toluidine blue. Consistent with the in vitro observation, no mast cell degranulation was mentioned (data not shown). 2 . We analyzed whether mast cell-derived 15-deoxydelta PGJ 2 could directly activate PPAR␥ expressed in NIH 3T3 fibroblasts. The PPRE reporter plasmids conjugated with the luciferase gene were introduced into NIH 3T3 fibroblasts (8, 17) , and transfected cells were cultured with the supernatants of BMCMC that were stimulated with A23187 for 24 h. After a 24-h incubation, the luciferase activity in the cells was analyzed by a luciferase assay. The luciferase activity in the NIH 3T3 fibroblasts cultured with the supernatants of A23187-stimulated BMCMC was upregulated, whereas addition of A23187 alone had no effect (Fig. 4) . GW9662 inhibited luciferase activity in the NIH 3T3 fibroblasts that were cocultured with A23187-stimulated BMCMC (Fig. 4) . Thus we concluded that 15-deoxy-delta PGJ 2 derived from BMCMC promoted PPAR␥ activation in the NIH 3T3 fibroblasts. We confirmed the same tendency in the experiment using supernatants from BMCMC cultured in the high-glucose condition (data not shown). However, its positive reactivity was quite low due to lower contents of 15-deoxy-delta PGJ 2 .
Direct activation of PPAR␥ by mast cell-derived 15-deoxydelta PGJ
Involvement of mast cells in weight gain in high-fat feeding through adiponectin regulation. To evaluate the role of mast cells in adipogenesis, we used mast cell-deficient WBB6F 1 -W/W v mice and their normal littermates as a control. Six-weekold mice were supplied with a high-fat diet (containing 40% lard) ad libitum for 28 days. The increase in the body weight of WBB6F 1 -W/W v mice fed with a high-fat diet did not exceed that of the control WBB6F 1 ϩ/ϩ mice (Fig. 5A) . Since weightgain defect in WBB6F 1 -W/W v mice was recovered after BMCMC transplantation (Fig. 5A) , impaired weight gain in WBB6F 1 -W/W v mice might be involved in mast cell deficiency. Moreover, transplantation of H-PGDS-deficient BMCMC did not affect the weight gain of WBB6F 1 -W/W v mice (Fig. 5A ), suggesting the importance of PGs in the process. After the high-fat feeding for 28 days, pioglitazone hydrochloride mixed with the high-fat diet (0.02%, wt/wt) was orally administered to WBB6F 1 -W/W v mice for the next 21 days; and the blood glucose, serum TG, and serum NEFA levels were measured to evaluate agonistic effects of pioglitazone on PPAR␥ (31) . The daily administration of pioglitazone suppressed the high-fat diet-induced increase in the levels of blood glucose and TG in WBB6F 1 -W/W v mice (Fig. 5B) . Although there was no statistical significance, the NAFA levels in the pioglitazoneadministered WBB6F 1 -W/W v mice tended to decrease after 3 wk (Fig. 5B) .
We also analyzed other factors relating to the growth of adipose tissues. Expression levels of factors necessary for the growth of adipose tissue were determined by a real time PCR analysis with adipose tissue isolated from control WBB6F 1 ϩ/ϩ and WBB6F 1 -W/W v mice fed with a high-fat diet. No significant differences in expression levels of TNF-␣, resistin, and leptin were recognized; however, adiponectin expression was increased in fat tissue of WBB6F 1 -W/W v mice fed with a high-fat diet than that of control WBB6F 1 ϩ/ϩ mice (Fig. 5C) . Amounts of circulating resistin, IL-6, and TNF-␣ were measured with ELISA kits and found that serum levels of those in WBB6F 1 ϩ/ϩ mice, intact WBB6F 1 -W/W v mice, and BM-CMC-transplanted WBB6F 1 -W/W v mice were all under the detection limit (data not shown). Serum levels of adiponectin in WBB6F 1 -W/W v mice fed with a high-fat diet tended to increase; however, those were within the normal range without any statistical differences in each group (Fig. 5D) .
DISCUSSION
Large numbers of mast cells were found in adipose tissue, particularly in mice fed with a high-fat diet, suggesting the possible involvement of mast cells in proliferation and/or functions of adipocytes. Culture supernatants from intact mast cells incubated in the high-glucose condition included 15-deoxy-delta PGJ 2 and were capable of inducing adipocyte differentiation. Since H-PGDS-deficient BMCMC failed to induce adipocyte differentiation, PGs released in culture medium might be responsible for promoting the phenomenon. The effect was induced through PPAR␥ activation and was abolished by its antagonist. Mast cells might enable to affect adipogenesis when the glucose levels in peripheral tissue were elevated. Therefore, mast cells may involve weight gain in mice when they are fed with a high-fat diet. Liu et al. (28) recently reported that mast cells might be associated with obesity induced by a Western diet via white adipose tissue (WAT) growth. They speculated that mast cells in WAT induced angiogenesis and suppressed apoptosis of cells in WAT, resulting in obesity (28) . Results obtained in the present study not only confirmed their findings but also first demonstrated that mast cells contributed directly to adipocyte differentiation possibly at diabetic condition. Thus the presence of mast cells might regulate weight gain through induction of adipocyte differentiation.
The major secretory compartment of adipose tissue consists of adipocytes, fibroblasts, and mast cells (7) . These cells secrete multiple bioactive molecules, classified as adipokines (7, 32) . We found that mRNA levels of adiponectin were increased in adipose tissues of mast cell-deficient mice fed with a high-fat diet; however, the serum level was not different from each group. Hypoadiponectinemia is associated with obesity and insulin resistance (3, 15, 19, 43) . Although direct correlation has been uncertain, the possible contribution of mast cells to weight gain through negative regulation of adiponectin is speculated. On the other hand, the low level of adiponectin may contribute to accumulation of mast cells in fat tissue of wild-type mice during high-fat feeding as well as macrophages (45) . Accumulation of macrophages may be involved in insulin resistance by producing proinflammatory cytokines (45) . Mast cells have been reported to accumulate in obese adipose tissue before the appearance of macrophages and might induce obe- Fig. 3 . Production of 15-deoxy-delta-12,14-prostaglandin J2 (15-deoxy-delta PGJ2) in the culture supernatants of BMCMC. A: in culture medium collected from BMCMC stimulated with 1 M A23187, 15-deoxy-delta PGJ2 was detected in culture medium and reached maximal at 5 ϫ 10 6 cells/ml. On the other hand, the concentration of 15-deoxy-delta PGJ2 in medium alone was below the detection limit. Data represents means Ϯ SE of 4 different experiments in duplication. Two-tailed Student's t-test was performed for the statistical analysis of the data, and the level of significance was indicated as P values in the figure. B: when BMCMC (2.5 ϫ 10 7 cells/ml) were cultured with various concentrations of glucose for 72 h, the concentration of 15-deoxy-delta PGJ2 was increased in a dose-dependent manner. Data represents means Ϯ SE of 3 different experiments in duplication. Two-tailed Student's t-test was performed for the statistical analysis of the data, and the level of significance was indicated as P values in the figure. C: 15-deoxy-delta PGJ2 production from adipose tissue-derived cultured-mast cells (2.0 ϫ 10 7 cells/ml) incubated in the high-glucose condition for 72 h. The concentration of 15-deoxy-delta PGJ2 was increased dose dependently. Data represents means Ϯ SE of 3 different experiments in duplication. Two-tailed Student's t-test was performed for the statistical analysis of the data, and the level of significance was indicated as P values in the figure. sity via angiogenesis (23, 28) . The present results suggested that mast cells might promote adipogenesis directly through 15-deoxy-delta PGJ 2 production and indirectly through adiponectin regulation. Since formed lipid droplets were smaller in adipocytes cultured in BMCMC supernatants, mast cells might participate in initial differentiation but not maturation of adipocytes; therefore, the serum level of adiponectin may be less affected. In the current study, we demonstrated that 15-deoxy-delta PGJ 2 from mast cells cultured in the high-glucose condition induced the differentiation of adipocytes in vitro. The glucose concentration of cultured medium was much higher than blood glucose levels of patients with diabetes; however, the reactivity of mast cells against glucose exposure was revealed. Mast cells that reside in the organ and tissue associated with glucose uptake may be exposed in higher concentrations of glucose than periphery. Furthermore, as indicated in Fig. 3A , mast cells generate 15-deoxy-delta PGJ 2 in response to stimulation that activates membrane metabolism. Therefore, mast cells may contribute to adipogenesis in vivo even if in lower glucose environment. Concentrations of 15-deoxy-delta PGJ 2 in supernatants became maximal when 5 ϫ 10 6 BMCMC/ml were stimulated with A23187, which may due to the capacity of PG converting factors in culture medium. The recent study reported that long-term culture in the high-glucose condition augmented IgE-mediated activation of mast cells and leukotriene secretion (2) . The observation suggested that increased phosphorylation of cytosolic phospholipase (PL) A 2 of mast cells in high-glucose culture might contribute to the enhancement of membrane metabolism. Another finding provided evidence that activated T lymphocytes, through cyclooxygenase-mediated production of PGD 2 , profoundly influenced human fibroblast differentiation to adipocytes (13) . Further investigation must take place; however, triggering of PLA 2 cascade may be associated with PG production from mast cells cultured in high-glucose medium.
Presently, reported endogenous PPAR␥ agonists include free fatty acids, components of oxidized plasma lipoproteins (9-and 13-oxoODE, azPC), conjugated lysophosphatidic acid derivatives (CLA1 and CLA2), products of phospholipase hydrolysis of complex lipids (LPA), platelet-activating factor, and eicosanoid derivatives such as the dehydration product of PGD 2 15-deoxy-delta PGJ 2 (5, 9, 25) . More recently, fatty acid nitration products, which are formed via nitric oxide-dependent oxidative inflammatory reactions and are found in the blood of healthy individuals, have been reported to transduce nitric oxide-mediated cell signaling reactions and PPAR-dependent gene expression (34) . Endogenous ligands of PPAR␥, as well as synthetic agonists, may have potential activity in glucose and/or lipid metabolism. Based on results obtained in this study, we propose the following cascades for the roles of mast cells in response to glucose overload: 1) certain stimuli that induce the alteration of the membrane permeability promote prostanoid production from mast cells, 2) prostanoid produced from mast cells may be converted into its final metabolites 15-deoxy-delta PGJ 2 possibly by the converting enzymes that are present in the serum or tissue fluid, 3) mast cell-derived 15-deoxy-delta PGJ 2 activates PPAR␥ expressed in various cell types, 4) activation of PPAR␥ promotes adipocyte differentiation, and 5) the growth of adipose tissues is advanced. This is the first study that reports the role of mast cells in adipogenesis and proposes a new function of these cells.
